PARP1 and Alzheimer disease: Collectively, these findings support a crucial role of PARP-1 in the pathogenesis of AD and strongly suggest that targeting PARP-1 could be a promising strategy for minimizing the detrimental effects correlated with PARP-1 overactivation in AD.